《亞洲股市》日經及星菲股續跌0.8%-1.2% 惟深成及印尼逆市倒升不足0.5%
南非出現較Delta傳播力更快及對現有疫苗有抵抗力的已被世衛命名為Omicron的新變種病毒株,並已蔓延至多國,引發市場恐慌,環球股市及風險資產繼上周五急跌後,美股期貨全面反彈0.7%-1.2%,道指彈力較弱,報35,105,回升247點或0.7%,納指一百期貨彈近1.2%報16,240。亞太區股市今天跌至低位也見承接,尤其是日經曾收復續挫逾400點至28,335所有失地,倒升高見28,776,現報28,513,續跌237點或0.8%。
菲股低見7,000,現報7,190,續跌1.2%;印度孟買繼上周五急吐2.9%後,今早高低見57,307/56,382,現報56,806,續跌0.5%。
台灣加權指數低見17,167獲承接,曾倒升高見17,415,現報17,355,僅續跌13點。澳洲200高低見7,279/7,180,現報7,252,續跌不足0.4%。韓股高低見2,930/2,890,現報2,922,續跌0.5%。泰股承上周五挫2%勢,今早低見1,596獲承接,現報1,608,續跌0.1%。新加坡海峽時數五連跌,最低見3,127,現報3,132,續跌1%。澳紐股市續跌0.3%-0.5%,分別報7,258及12,563。
港股繼上周五急挫近2.7%後,今天在季績遜預期美團(03690.HK)及澳門中介業股東周焯華被捕事件引發沽壓的濠賭股銀娛(00027.HK)/金沙(01928.HK)續挫6.3%-7.8%拖累,曾續跌229點低見23,851喘定,在騰訊(00700.HK)/阿里巴巴(09988.HK)/阿里健康(00241.HK)/舜宇(02382.HK)反覆升1%-4%支撐,曾倒升見24,134,半日收23,956,續跌124點或0.5%。
滬指及深成低見3,526及14,633獲承接,半日收3,562及14,817,分別僅續跌1點及倒升0.3%。此外,印尼繼上周五挫2%後,今早低見6,487獲承接,掉頭高見6,601,現報6,590,倒升0.4%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.